QT interval prolongation and decreased heart rate variability in cirrhotic patients: Relevance of hepatic venous pressure gradient and serum calcium

Clinical Science

Volumn 116, Issue 11-12, 2009, Pages 851-859

  Genovesi, Simonetta ^a,b   Prata Pizzala, Daniela M ^b   Pozzi, Massimo ^b   Ratti, Laura ^b   Milanese, Maria ^b   Pieruzzi, Federico ^a,b   Vincenti, Antonio ^b   Stella, Andrea ^a   Mancia, Giuseppe ^b   Stramba Badiale, Marco ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Calcium; Cirrhosis; Heart rate variability; Portal hypertension; QT interval

Indexed keywords

ALDOSTERONE; CALCIUM; POTASSIUM;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALDOSTERONE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEART ARRHYTHMIA; HEART RATE; HEART RATE VARIABILITY; HEART REPOLARIZATION; HOLTER MONITORING; HUMAN; LIVER CIRRHOSIS; LIVER VEIN; MALE; PORTAL HYPERTENSION; POTASSIUM BLOOD LEVEL; PRESSURE GRADIENT; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RR INTERVAL; VAGUS NERVE STIMULATION; VENOUS PRESSURE; VIRUS HEPATITIS; DISEASE COURSE; HEPATIC VENOUS PRESSURE GRADIENT; HUMAN TISSUE; VIRAL LIVER CIRRHOSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; CALCIUM; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; LIVER CIRRHOSIS; LONG QT SYNDROME; MALE; MIDDLE AGED; PORTAL PRESSURE;

EID: 67649265344     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080325     Document Type: Article

References (41)

1. Kowalski, H. J. and Abelmann, W. H. (1953) The cardiac output at rest in Laennec's cirrhosis. J. Clin. Invest. 32, 1025-1033
2. Schrier, R. W., Arroyo, V., Bernardi, M., Epstein, M., Henriksen, J. H. and Rodes, J. (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8, 1151-1157 (Pubitemid 18236621)
3. Bernardi, M., Calandra, S., Colantoni, A., Trevisani, F., Raimondo, M. L., Sica, G., Schepis, F., Mandini, M., Simoni, P., Contin, M. and Raimondo, G. (1998) Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 27, 28-34 (Pubitemid 28041530)
4. Ma, Z. and Lee, S. S. (1996) Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 24, 451-459 (Pubitemid 26260046)
5. Henriksen, J. H., Fuglsang, S., Bendtsen, F., Christensen, E. and Moller, S. (2002) Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J. Hepatol. 36, 513-520 (Pubitemid 34407340)
6. Ytting, H., Henriksen, J. H., Fuglsang, S., Bendtsen, F. and Moller, S. (2005) Prolonged QT(c) interval in mild portal hypertensive cirrhosis. J. Hepatol. 43, 637-644 (Pubitemid 41253231)
7. Zambruni, A., Trevisani, F., Caraceni, P. and Bernardi, M. (2006) Cardiac electrophysiological abnormalities in patients with cirrhosis. J. Hepatol. 44, 994-1002
8. Algra, A., Tijssen, J. G., Roelandt, J. R., Pool, J. and Lubsen, J. (1991) QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 83, 1888-1894
9. Schouten, E. G., Dekker, J. M., Meppelink, P., Kok, F. J., Vandenbroucke, J. P. and Pool, J. (1991) QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84, 1516-1523
10. Schwartz, P. J., Stramba-Badiale, M., Segantini, A., Austoni, P., Bosi, G., Giorgetti, R., Grancini, F., Marni, E. D., Perticone, F., Rosti, D. and Salice, P. (1998) Prolongation of the QT interval and the sudden infant death syndrome. N. Engl. J. Med. 338, 1709-1714
11. Faigel, D. O., Metz, D. C. and Kochman, M. L. (1995) Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance. Am. J. Gastroenterol. 90, 822-824
12. Kamisako, T., Adachi, Y., Nakagawa, H. and Yamamoto, T. (1995) Torsades de pointes associated with terfenadine in a case of liver cirrhosis and hepatocellular carcinoma. Intern. Med. 34, 92-95
13. Nakasone, H., Sugama, R., Sakugawa, H., Matayoshi, R., Miyagi, T., Maeshiro, T., Yamashiro, T., Higa, F., Hokama, A., Kinjo, F. et al. (2001) Alcoholic liver cirrhosis complicated with torsade de pointes during plasma exchange and hemodiafiltration. J. Gastroenterol. 36, 564-568 (Pubitemid 32791845)
14. Di Micoli, A., Bracci, E., Cappa, F. M., Casadio, R., Zambruni, A., Fontana, K., Bernardi, M. and Trevisani, F. (2008) Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome. Dig. Liver Dis. 40, 304-305
15. Li, L., Liu, H. R., Shu, J. L., Xi, X. P. and Wang, Y. (2007) Clinical investigation of Q-T prolongation in hepatic cirrhosis. Zhonghua Yi Xue Za Zhi 87, 2717-2718 (Pubitemid 351148326)
16. Trevisani, F., Merli, M., Savelli, F., Valeriano, V., Zambruni, A., Riggio, O., Caraceni, P., Domenicali, M. and Bernardi, M. (2003) QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J. Hepatol. 38, 461-467 (Pubitemid 36399249)
17. Pugh, R. N., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C. and Williams, R. (1973) Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60, 646-649
18. Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S. et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18, 1440-1463
19. Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I. and Reichek, N. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 57, 450-458
20. Bal, J. S. and Thuluvath, P. J. (2003) Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int. 23, 243-248 (Pubitemid 37265799)
21. Vorobioff, J. D. (2007) Hepatic venous pressure in practice: how, when, and why. J. Clin. Gastroenterol. 41, S336-S343
22. Genovesi, S., Dossi, C., Vigano, M. R., Galbiati, E., Prolo, F., Stella, A. and Stramba-Badiale, M. (2008) Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace 10, 771-777 (Pubitemid 351775262)
23. Ter Keurs, H. E. and Boyden, P. A. (2007) Calcium and arrhythmogenesis. Physiol. Rev. 87, 457-506
24. Mawer, E. B., Klass, H. J., Warnes, T. W. and Berry, J. L. (1985) Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease. Clin. Sci. 69, 561-570
25. Collier, J. D., Ninkovic, M. and Compston, J. E. (2002) Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50, i1-i9 (Pubitemid 41185465)
26. Zambruni, A., Di, M. A., Lubisco, A., Domenicali, M., Trevisani, F. and Bernardi, M. (2007) QT interval correction in patients with cirrhosis. J. Cardiovasc. Electrophysiol. 18, 77-82
27. Hansen, S., Moller, S., Bendtsen, F., Jensen, G. and Henriksen, J. H. (2007) Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes. J. Hepatol. 47, 373-380 (Pubitemid 47189606)
28. Stramba-Badiale, M., Locati, E. H., Martinelli, A., Courville, J. and Schwartz, P. J. (1997) Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur. Heart J. 18, 1000-1006
29. Roden, D. M., Woosley, R. L. and Primm, R. K. (1986) Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am. Heart J. 111, 1088-1093
30. Day, C. P., James, O. F., Butler, T. J. and Campbell, R. W. (1993) QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 341, 1423-1428 (Pubitemid 23161442)
31. Henriksen, J. H., Ring-Larsen, H. and Christensen, N. J. (1985) Circulating noradrenaline and central haemodynamics in patients with cirrhosis. Scand. J. Gastroenterol. 20, 1185-1190
32. Nicholls, K. M., Shapiro, M. D., Van, P. V., Kluge, R., Chung, H. M., Bichet, D. G. and Schrier, R. W. (1985) Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion. Circ. Res. 56, 457-461
33. Floras, J. S., Legault, L., Morali, G. A., Hara, K. and Blendis, L. M. (1991) Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann. Intern. Med. 114, 373-380
34. Pozzi, M., Grassi, G., Pecci, V., Turri, C., Boari, G., Bolla, G. B., Dell'oro, R., Massironi, S., Roffi, L. and Mancia, G. (1999) Early effects of total paracentesis and albumin infusion on muscle sympathetic nerve activity in cirrhotic patients with tense ascites. J. Hepatol. 30, 95-100
35. Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M. and Shusterman, N. H. (1996) The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N. Engl. J. Med. 334, 1349-1355
36. Fauchier, L., Pierre, B., de Labriolle, A. and Babuty, D. (2007) Comparison of the beneficial effect of β-blockers on mortality in patients with ischaemic or non-ischaemic systolic heart failure: a meta-analysis of randomised controlled trials. Eur. J. Heart Failure 9, 1136-1139 (Pubitemid 47633317)
37. Gottlieb, S. S., McCarter, R. J. and Vogel, R. A. (1998) Effect of β-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N. Engl. J. Med. 339, 489-497
38. Dargie, H. J. (2001) Effect of Carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357, 1385-1390 (Pubitemid 32455364)
39. Zambruni, A., Trevisani, F., Di Micoli, A., Savelli, F., Berzigotti, A., Bracci, E., Caraceni, P., Domenicali, M., Felline, P., Zoli, M. and Bernardi, M. (2008) Effect of chronic β-blockade on QT interval in patients with liver cirrhosis. J. Hepatol. 48, 415-421
40. Henriksen, J. H., Bendtsen, F., Hansen, E. F. and Moller, S. (2004) Acute non-selective β-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. J. Hepatol. 40, 239-246 (Pubitemid 38115828)
41. Stramba-Badiale, M., Goulene, K. and Schwartz, P. J. (1997) Effects of β-adrenergic blockade on dispersion of ventricular repolarization in newborn infants with prolonged QT interval. Am. Heart J. 134, 40-410